| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 02/19/2003 | CN1398189A Combination therapy of radiation and COX-2 inhibitor for treatment of neoplasia |
| 02/19/2003 | CN1398182A Dual inhibitors of cholestery lester and wax ester synthesis for sebaceous gland disorders |
| 02/19/2003 | CN1398179A Cosmetic prepns. contg. waltheria indica extracts |
| 02/19/2003 | CN1397556A Alkali-metal or alkali-earth metal salt of polyprotic acid delotadine and its medical composition |
| 02/19/2003 | CN1397343A Process for preparing externally-applied Chinese medicine as liniment containing ganoderma and tendrilled fritillary bulb |
| 02/19/2003 | CN1397342A Process for preparing externally-applied Chinese medicine as liniment containing liquorice root and ganoderma |
| 02/19/2003 | CN1397341A Medicine for treating psoriasis |
| 02/19/2003 | CN1397330A Ointment for treating burn and scald |
| 02/19/2003 | CN1397329A Medicine for treating acne and its preparing process |
| 02/19/2003 | CN1397328A Oral liquid for treating wart |
| 02/19/2003 | CN1397327A Liquid medicine for treating dermatopathy |
| 02/19/2003 | CN1397321A Prescription and preparing process for compound spanishneedles ointment |
| 02/19/2003 | CN1397320A Ointment for treating burn and scald |
| 02/19/2003 | CN1397311A 'Putiqudou' ointment for treating acne |
| 02/19/2003 | CN1397310A Process for preparing externally-applied Chinese medicine as liniment containing ganoderma and pinellia tuber |
| 02/19/2003 | CN1397309A Process for preparing externally-applied Chinese medicine as liniment containing cinammon bark and amomum fruit |
| 02/19/2003 | CN1397308A Process for preparing externally-applied Chinese medicine as liniment containing tuckahoe and ginseng |
| 02/19/2003 | CN1397307A Process for preparing externally-applied Chinese medicine as liniment containing cinammon bark and acanthopanax bark |
| 02/19/2003 | CN1397306A Process for preparing externally-applied Chinese medicine as liniment containing dried ginger and tuckahoe |
| 02/19/2003 | CN1397305A Process for preparing externally-applied Chinese medicine as liniment containing agastache and Chuan-xiong rhizome |
| 02/19/2003 | CN1397304A Process for preparing externally-applied Chinese medicine as liniment containing liquorice root and amomum fruit |
| 02/19/2003 | CN1397303A Process for preparing externally-applied Chinese medicine as liniment containing |
| 02/19/2003 | CN1397302A Process for preparing externally-applied Chinese medicine as liniment containing saffron and eagle wood |
| 02/19/2003 | CN1397301A Process for preparing externally-applied Chinese medicine as liniment containing fleece flower root and wolfberry fruit |
| 02/19/2003 | CN1397300A Process for preparing externally-applied Chinese medicine as liniment containing Monordica grosvenori and cloves |
| 02/19/2003 | CN1397299A Process for preparing externally-applied Chinese medicine as liniment containing honeysuckle flower and black plum |
| 02/19/2003 | CN1397298A Process for preparing externally-applied Chinese medicine as liniment containing fleece flower root and white atractylodes rhizome |
| 02/19/2003 | CN1397297A Process for preparing externally-applied Chinese medicine as liniment containing gastrodia tuber and almond |
| 02/19/2003 | CN1397296A Process for prparing externally-applied Chinese medicine as liniment containing saffron and chrysanthemum flower |
| 02/19/2003 | CN1397295A Process for preparing externally-applied Chinese medicine as liniment containing haw and lily bulb |
| 02/19/2003 | CN1397294A Process for preparing externally-applied Chiense medicine as liniment containing red jujube and black plum |
| 02/19/2003 | CN1397292A Externally-applied medicine for treaitng red swelling |
| 02/19/2003 | CN1397270A Skin nursing care |
| 02/19/2003 | CN1397266A Natural hair-growing cream coated on eyebrow |
| 02/19/2003 | CN1101703C Liquid medicine for radically treating wart |
| 02/19/2003 | CN1101691C Acne eliminating capsule and liniment for treating acnes |
| 02/19/2003 | CN1101688C Chinese herbal medicine preparation for treating keloid |
| 02/18/2003 | WO2002016329A1 Novel phenylalanine derivatives |
| 02/18/2003 | US6521759 Aminothiazole inhibitors of cyclin dependent kinases |
| 02/18/2003 | US6521669 Hydroxystilbene compounds for reducing/inhibiting protein glycation |
| 02/18/2003 | US6521646 Integrin inhibitors |
| 02/18/2003 | US6521643 Pyridine compounds and their pharmaceutical use |
| 02/18/2003 | US6521620 Suppressing tumors, especially breast cancers; antiproli-ferative agents; arthritis, vascular restenosis, psoriasis and angiogenesis; extremely low cytotoxicity |
| 02/18/2003 | US6521606 Matrix metalloproteinase inhibitors |
| 02/18/2003 | US6521437 Human sphingosine lyase polypeptides |
| 02/18/2003 | US6521267 Tyrosinase inhibitors from plants |
| 02/18/2003 | US6521251 Methods for treating burns on mammalian skin to reduce the risk of infection and to minimize fluid loss |
| 02/18/2003 | US6521248 Cavitation; reduced pressure; oxygenated water |
| 02/18/2003 | US6521242 Method for sequestration of nasal secretion skin irritants with facial tissue |
| 02/18/2003 | US6521241 That can bind a cytokine; clay, silica, titanium dioxide, and combinations thereof |
| 02/18/2003 | US6521240 That can bind a cytokine; clay, silica, titanium dioxide, and combinations thereof |
| 02/18/2003 | CA2420042A1 Carboxylic acid derivatives, processes for the preparation thereof and pharmaceutical agents comprising the same as active ingredient |
| 02/18/2003 | CA2283450C Methods for treatment of scar tissue |
| 02/18/2003 | CA2218750C Topical treatment and/or prevention of sagging subcutaneous muscle and overlying cutaneous tissue using acetylcholine precursors and catecholamines |
| 02/18/2003 | CA2112237C Cosmetic compositions containing oligosaccharides |
| 02/13/2003 | WO2003012441A1 Method for detecting modulators of notch signalling |
| 02/13/2003 | WO2003012122A2 Crystallized structure of type iv collagen nc1 domain hexamer |
| 02/13/2003 | WO2003012111A2 Conjugates for the modulation of immune responses |
| 02/13/2003 | WO2003012105A2 Vegf isoform |
| 02/13/2003 | WO2003011868A1 Thienopyrimidinediones and their use in the modulation of autoimmune disease |
| 02/13/2003 | WO2003011855A2 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | WO2003011854A1 Pyrazole-derived kinase inhibitors and uses thereof |
| 02/13/2003 | WO2003011842A1 Indane acetic acid derivatives and their use as pharmaceutical agents, intermediates, and method of preparation |
| 02/13/2003 | WO2003011841A1 1,2,4-triazin-3,5-diones as gonadotropin-releasing hormone receptor (gnrh) antagonists |
| 02/13/2003 | WO2003011830A1 Heteroarylheteroalkylamine derivatives and their use as inhibitors of nitric oxide synthase |
| 02/13/2003 | WO2003011812A1 NOVEL AMINE DERIVATIVE HAVING HUMAN β-TRYPTASE INHIBITORY ACTIVITY AND DRUGS CONTAINING THE SAME |
| 02/13/2003 | WO2003011808A1 Retinoid derivatives with antiangiogenic, antitumoral and proapoptotic activities |
| 02/13/2003 | WO2003011807A1 Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
| 02/13/2003 | WO2003011333A1 Botulinum toxin in the treatment or prevention of acne |
| 02/13/2003 | WO2003011329A2 Vaccine for prophylaxis and therapy of dermatophytosis in veterinary and human medicine |
| 02/13/2003 | WO2003011317A1 Modulators of notch signalling for use in immunotherapy |
| 02/13/2003 | WO2003011314A2 Use of lhrh-antagonists for the improvement of t-cell mediated immunity |
| 02/13/2003 | WO2003011304A1 Modulation of insulin-regulated aminopeptidase (irap)/angiotensin iv (at4) receptor activity |
| 02/13/2003 | WO2003011303A1 Dermal therapy using phosphate derivatives of electron transfer agents |
| 02/13/2003 | WO2003011302A1 Androgen receptor modulators and methods of use thereof |
| 02/13/2003 | WO2003011287A1 Pyrazolon derivatives as inhibitors of gsk-3 |
| 02/13/2003 | WO2003011285A1 BENZIMIDAZO[4,5-f]ISOQUINOLINONE DERIVATIVES |
| 02/13/2003 | WO2003011277A2 Methods to mobilize progenitor/stem cells |
| 02/13/2003 | WO2003011276A1 Nf?b inhibitor |
| 02/13/2003 | WO2003011265A2 5-aminolevulinic acid and esters, in combination with another phtosensitizer, as photosensitizing agents in photochemotherapy, and their uses in treating wounds |
| 02/13/2003 | WO2003011262A2 Use of 2-alkoxyphenyl-substituted imidazotriazinones for the treatment of diseases associated with cgmp regulated processes |
| 02/13/2003 | WO2003011252A1 Pharmaceutical composition comprising lipids comprising a polar and a nonpolar moiety |
| 02/13/2003 | WO2003011243A1 Invert emulsion containing dhea |
| 02/13/2003 | WO2003011242A1 Cosmetic or dermatological preparations containing a combination of creatinine and/or creatinine derivatives and creatine and/or the derivatives thereof |
| 02/13/2003 | WO2003011241A1 Utilization of creatinine and/or creatinine derivatives in cosmetic and dermatological preparations |
| 02/13/2003 | WO2003011239A2 Sunscreen composition |
| 02/13/2003 | WO2003011224A2 Pharmaceutical compositions containing beta-lapachone, or derivatives or analogs thereof, and methods of using same |
| 02/13/2003 | WO2003011219A2 Mediators of hedgehog signaling pathways, compositions and uses related thereto |
| 02/13/2003 | WO2003011217A2 Grifola extracts and methods of use thereof |
| 02/13/2003 | WO2002096457A3 Stable liquid formulations of antibodies |
| 02/13/2003 | WO2002092026A3 Dermatological and cosmetic compositions |
| 02/13/2003 | WO2002076995A3 2-amino-propanol derivatives |
| 02/13/2003 | WO2002074231A3 Cosmetic and dermopharmaceutical compositions comprising standardised extracts of hierochloe odorata |
| 02/13/2003 | WO2002069925A3 Use of $g(a)-lipoic acid in cosmetic or dermatological preparations |
| 02/13/2003 | WO2002060482A3 Perylenequinones for use with immunotherapy agents |
| 02/13/2003 | WO2002046192A3 Thioether substituted imidazoquinolines |
| 02/13/2003 | WO2002034283A3 Vegh inhibitors and their use |
| 02/13/2003 | WO2002031115A3 Nucleic acid molecules and polypeptides for immune modulation |
| 02/13/2003 | WO2002026325A9 Restoration of perturbed barrier function by application of antiandrogens |
| 02/13/2003 | US20030032804 Methods of treating periodontal disease |